DOTA-(Tyr3)-octreotate Trifluoroacetate
98%
- Product Code: 95846
CAS:
177943-89-4
| Molecular Weight: | 1495.67 g./mol | Molecular Formula: | C₆₇H₉₄N₁₄O₂₁S₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, protected from light, inert gas |
Product Description:
This compound is primarily used in nuclear medicine for diagnostic imaging and targeted radiotherapy, particularly in the detection and treatment of neuroendocrine tumors (NETs). It acts as a chelating agent, binding to radioactive isotopes such as lutetium-177 or gallium-68, which are then used in positron emission tomography (PET) scans or radionuclide therapy. The compound specifically targets somatostatin receptors, which are overexpressed in many NETs, allowing for precise localization and treatment of these tumors. Its application enhances the accuracy of tumor imaging and improves the efficacy of therapeutic interventions while minimizing damage to surrounding healthy tissues.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | $745.86 |
+
-
|
DOTA-(Tyr3)-octreotate Trifluoroacetate
This compound is primarily used in nuclear medicine for diagnostic imaging and targeted radiotherapy, particularly in the detection and treatment of neuroendocrine tumors (NETs). It acts as a chelating agent, binding to radioactive isotopes such as lutetium-177 or gallium-68, which are then used in positron emission tomography (PET) scans or radionuclide therapy. The compound specifically targets somatostatin receptors, which are overexpressed in many NETs, allowing for precise localization and treatment of these tumors. Its application enhances the accuracy of tumor imaging and improves the efficacy of therapeutic interventions while minimizing damage to surrounding healthy tissues.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :